drugset

drugset / Trial / NCT04565925

Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

NCT04565925 ↗

Phase 2 Recruiting 24 enrolled The University of Texas Medical Branch, Galveston

RandomizedCrossoverTriple-blindTreatment

Summary

The goal of this study is to determine whether administration of sildenafil will decrease urine leakage in patients with spinal cord injuries.

Timeline

Start: 2021-07-07
Primary completion: 2026-12-01
Completion: 2026-12-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sildenafil	Unknown	20 mg	—

Indications